For: | Zhi J, Jia XJ, Yan J, Wang HC, Feng B, Xing HY, Jia YT. BRAFV600E mutant colorectal cancer cells mediate local immunosuppressive microenvironment through exosomal long noncoding RNAs. World J Gastrointest Oncol 2021; 13(12): 2129-2148 [PMID: 35070047 DOI: 10.4251/wjgo.v13.i12.2129] |
---|---|
URL: | https://www.wjgnet.com/1948-5204/full/v13/i12/2129.htm |
Number | Citing Articles |
1 |
Wenjing Li, Chenyi Zhao, Wenhui Li, Yang Gong, Kaili Ma, Yujie Lu, Xiaowei Liu, Lianjun Zhang, Feng Guo. BRAF D594A mutation defines a unique biological and immuno-modulatory subgroup associated with functional CD8+ T cell infiltration in colorectal cancer. Journal of Translational Medicine 2023; 21(1) doi: 10.1186/s12967-023-04606-5
|
2 |
Fanhua Kang, Feng Jiang, Lingzi Ouyang, Shangjun Wu, Chencheng Fu, Ying Liu, Zhilan Li, Yu Tian, Xiaolan Cao, Xiaoping Wang, Qingchun He. Potential Biological Roles of Exosomal Long Non-Coding RNAs in Gastrointestinal Cancer. Frontiers in Cell and Developmental Biology 2022; 10 doi: 10.3389/fcell.2022.886191
|
3 |
Jie Zhong, Zijian Sun, Sheng Li, Liu Yang, Yuepeng Cao, Jun Bao. Immune checkpoint blockade therapy for BRAF mutant metastatic colorectal cancer: the efficacy, new strategies, and potential biomarkers. Discover Oncology 2023; 14(1) doi: 10.1007/s12672-023-00718-y
|
4 |
Juanzi Zeng, Wenwei Fan, Jiaquan Li, Guowu Wu, Heming Wu. KRAS/NRAS Mutations Associated with Distant Metastasis and BRAF/PIK3CA Mutations Associated with Poor Tumor Differentiation in Colorectal Cancer. International Journal of General Medicine 2023; : 4109 doi: 10.2147/IJGM.S428580
|
5 |
Rahaba Marima, Afra Basera, Thabiso Miya, Botle Precious Damane, Jeyalakshmi Kandhavelu, Sheefa Mirza, Clement Penny, Zodwa Dlamini. Exosomal long non-coding RNAs in cancer: Interplay, modulation, and therapeutic avenues. Non-coding RNA Research 2024; 9(3): 887 doi: 10.1016/j.ncrna.2024.03.014
|
6 |
Wenqin Zhang, Yuanliang Yan, Jinwu Peng, Abhimanyu Thakur, Ning Bai, Keda Yang, Zhijie Xu. Decoding Roles of Exosomal lncRNAs in Tumor-Immune Regulation and Therapeutic Potential. Cancers 2022; 15(1): 286 doi: 10.3390/cancers15010286
|
7 |
Weihao Deng, Xiaoxia Liu, Shuhui Huang, Zhijie Wu, Fichera Alessandro, Qingfeng Lin, Zonglu Cai, Zitong Zhang, Yan Huang, Hui Wang, Zixu Yuan. CXCL16 promotes tumor metastasis by regulating angiogenesis in the tumor micro-environment of BRAF V600E mutant colorectal cancer. Translational Oncology 2024; 41: 101854 doi: 10.1016/j.tranon.2023.101854
|
8 |
Hassan Mohammed Abushukair, Sara Mu'amar Zaitoun, Anwaar Saeed. Insight on BRAF<sup>V600E</sup> mutated colorectal cancer immune microenvironment. World Journal of Gastrointestinal Oncology 2022; 14(6): 1213-1215 doi: 10.4251/wjgo.v14.i6.1213
|
9 |
Jiyang Wu, Xiaoxing Wang, Zhengzhe Li, Xiaomei Yi, Die Hu, Qi Wang, Tianyu Zhong. Small extracellular vesicles promote the formation of the pre-metastatic niche through multiple mechanisms in colorectal cancer. Cell Cycle 2024; 23(2): 131 doi: 10.1080/15384101.2024.2311501
|
10 |
Susana García-Silva, Héctor Peinado. Mechanisms of lymph node metastasis: An extracellular vesicle perspective. European Journal of Cell Biology 2024; 103(3): 151447 doi: 10.1016/j.ejcb.2024.151447
|
11 |
Yuntong Sun, Fengtian Sun, Jianhua Jin, Wenrong Xu, Hui Qian. Exosomal LncRNAs in Gastrointestinal Cancer: Biological Functions and Emerging Clinical Applications. Cancers 2023; 15(3): 959 doi: 10.3390/cancers15030959
|
12 |
Jiali Yao, Yingrui Chen, Zhijie Lin. Exosomes: Mediators in microenvironment of colorectal cancer. International Journal of Cancer 2023; 153(5): 904 doi: 10.1002/ijc.34471
|
13 |
Wen-Chun Lin, Chun-Chi Lin, Yen-Yu Lin, Wen-Hao Yang, Yuh-Ching Twu, Hao-Wei Teng, Wei-Lun Hwang. Molecular actions of exosomes and their theragnostics in colorectal cancer: current findings and limitations. Cellular Oncology 2022; 45(6): 1043 doi: 10.1007/s13402-022-00711-7
|
14 |
Alfredo Colombo, Stefano Cordio, Concetta Maria Porretto. Immune check point inhibitors in BRAF mutated metastatic colorectal cancer: A review. International Journal of Gastrointestinal Intervention 2024; 13(3): 74 doi: 10.18528/ijgii240030
|
15 |
Mai Hazekawa, Takuya Nishinakagawa, Masato Hosokawa, Daisuke Ishibashi. Development of an Organ-Directed Exosome-Based siRNA-Carrier Derived from Autologous Serum for Lung Metastases and Testing in the B16/BL6 Spontaneous Lung Metastasis Model. Pharmaceutics 2022; 14(4): 815 doi: 10.3390/pharmaceutics14040815
|
16 |
José A. Peña-Flores, Daniela Muela-Campos, Rebeca Guzmán-Medrano, Diego Enríquez-Espinoza, Karla González-Alvarado. Functional Relevance of Extracellular Vesicle-Derived Long Non-Coding and Circular RNAs in Cancer Angiogenesis. Non-Coding RNA 2024; 10(1): 12 doi: 10.3390/ncrna10010012
|
17 |
Wenjie Zhang, Zhengting Jiang, Dong Tang. The value of exosome-derived noncoding RNAs in colorectal cancer proliferation, metastasis, and clinical applications. Clinical and Translational Oncology 2022; 24(12): 2305 doi: 10.1007/s12094-022-02908-6
|
18 |
Sunao Ito, Akira Koshino, Chengbo Wang, Takahiro Otani, Masayuki Komura, Akane Ueki, Shunsuke Kato, Hiroki Takahashi, Masahide Ebi, Naotaka Ogasawara, Toyonori Tsuzuki, Kenji Kasai, Kunio Kasugai, Shuji Takiguchi, Satoru Takahashi, Shingo Inaguma. Characterisation of colorectal cancer by hierarchical clustering analyses for five stroma‐related markers. The Journal of Pathology: Clinical Research 2024; 10(4) doi: 10.1002/2056-4538.12386
|
19 |
Mengling Liu, Qing Liu, Keshu Hu, Yu Dong, Xun Sun, Zhiguo Zou, Dingkun Ji, Tianshu Liu, Yiyi Yu. Colorectal cancer with BRAF V600E mutation: Trends in immune checkpoint inhibitor treatment. Critical Reviews in Oncology/Hematology 2024; 204: 104497 doi: 10.1016/j.critrevonc.2024.104497
|